Meticulous Research® –leading global market research company published a research report titled “Mice Model Market by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice), Service (Breeding, Rederivation), Therapeutic Area (Oncology, Heart Disease), Technology (CRISPR Cas9, SCNT), Mice Care Product (Cage, Feed), and End User- Global Forecast to 2023”.
According to this latest publication from Meticulous Research®, the global mice model market is poised to grow at a CAGR of 7.2% from 2018 to 2023 to reach USD 1,370.5 million by 2023, driven by continuing modification in mice model for cancers, immune diseases, and rare diseases; increasing devouring of personalized medicine propelling the demand for humanized mice model; rising grants and investments for biological research; rising pharmaceutical R&D activities; and increasing focus of the International Mouse Phenotyping Consortium (IMPC) and International Knockout Mouse Consortium (IKMC) on the development of embryonic stem cells as well as knockout and mutant mice. Moreover, evolution of CRISPR-Cas9 gene editing technology in the field of biomedical research, increasing demand for humanized mice model, and rising monoclonal antibody production provides significant opportunities in this market. However, increasing use of rat models, increased advantage from cryopreservation, and stringent government regulations and laws for ethical use of animals in research hinders the growth of mice model market to some extent.
Browse in-depth Report on:https://www.meticulousresearch.com/product/mice-model-market/
The global mice model market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018) and forecasts for 2023- by type (inbred mice, outbred mice, genetically engineered mice, hybrid mice, immunodeficient mice, and spontaneous mutant), service (breeding, cryopreservation & cryorecovery, quarantine, rederivation, model in licensing, genetic testing, and other services), therapeutic area (oncology, immunology & inflammation, cardiovascular, diabetes, neurobiology, rare diseases, and other diseases), technology (CRISPR-Cas9, embryonic stem cell injection, microinjection, somatic cell nuclear transfer, other technologies), mice care products (cages, feed, bedding, others), and end user (academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and others). The study also evaluates industry competitors and analyzes the market at regional and country level.
The inbred mice models are being widely adopted for huge preclinical trials during drug discovery process. These models held the largest share in 2017; however, genetically engineered mice models are set to be the emerging and rapidly growing type of mice model.
Services form an essential part of the mice model market and breeding services comprised the major share in 2017. This segment is expected to witness the fastest growth mainly attributed to their ability to produce adequate quantity of desired litters which help researchers to conduct various preclinical trials during drug discovery process.
This research report analyzes major geographies and provides comprehensive analysis of North America (U.S. and Canada), Europe (Germany, U.K., France, Italy, Spain, and RoE), Asia-Pacific (Japan,China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America accounted for the major share in the global mice model market in 2017, followed by Europe, and Asia-Pacific. The major share of the North American region is mainly attributed to the presence of established pharmaceutical & biotechnology industry and advanced biomedical research field showing huge demand for mice model for the drug discovery process, increasing R&D expenditure, and various government initiatives. However, Asia-Pacific region possesses lucrative growth potential for the mice model market during the forecast period. This is mainly attributed to the increasing growth in government & private sector, growing biomedical & personalized research areas, and rising focus on the regenerative medicine in order to understand the translational research field.
The key players in the global mice model market are Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Laboratory Corporation of America Holdings (U.S.), Horizon Discovery Group plc (U.K.), Trans Genic Inc. (Japan), genOway (France), Taconic Biosciences, Inc. (U.S.), Envigo (U.S.), JANVIER LABS (France), Ingenious Targeting Laboratory (U.S.), and Harbour Antibodies BV (The Netherlands).
Key questions answered in the report-
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123